Anaphylactic reaction to praziquantel following schistosomiasis treatment

Vasconcelos, Géssica Almeida; Costa, Bernardo Gratival Gouvea; Santos, Ronald Alves dos; Faria, Carolina Dourado de; Schramm Neto, Fernando Antônio Ramos; Machado, Yuri de Jesus; Casaes, Ane Caroline; Oliveira, Marcos Vinicius Lima de; Fialho, Thainá Rodrigues de Souza; Santos, Keila Ramos dos; Oliveira, Bruna Souza S.; Oliveira, Ricardo Riccio; Siqueira, Isadora Cristina de.
Artículo en Inglés | ARCA | ID: arc-60820

Documentos relacionados

  1. Advances in new target molecules against schistosomiasis: A comprehensive discussion of physiological structure and nutrient intake.
  2. Considering ivermectin for treatment of schistosomiasis.
  3. Prediction of antischistosomal small molecules using machine learning in the era of big data.
  4. From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity.
  5. Seroconversion following empiric praziquantel treatment as confirmatory diagnostic tool for chronic schistosomiasis.
  6. Low awareness and common misconceptions about schistosomiasis in endemic lowland areas in Western Ethiopia: a mixed-methods study.
  7. Activities of Quinoxaline, Nitroquinoxaline, and [1,2,4]Triazolo[4,3-a]quinoxaline Analogs of MMV007204 against Schistosoma mansoni.
  8. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
  9. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum.
  10. In vitro and In silico assessment of antischistosomal activities of ethanolic extract of Cornulacamonacantha.